CWEB
Direxion Daily CSI China Internet Bull 2X Shares
Mentions (24Hr)
0.00% Today
Reddit Posts
Charlotte's Web - Some research into the newly proposed board members
Why I Believe Charlotte's Web CBD Is About To Be Acquired by British American Tobacco or Organigram (DD inside)
Good morning! 🌞 #premarket #watchlist 03/16 $DIDI - volatility in china, $ZH - volatility in china, $FUTU -volatility in china, $PDD - volatility in china, $IQ - volatility in china, $BILI - volatility in china, $CWEB - china ... Also check afterhours runners and low float stocks in my app!
Anyone still holding on to CWEB?
Why Investors Are Excited About Sundial Growers Repurchase Of $100 Million Shares - CWEB.com - Trending News, Business , Sports, Technology, Celebrity, Cooking Recipes
Calls on a levered China ETF CWEB up 100%+ in less than 5 days.
Tokyo Catalyst? 3 CBD Stocks Expanding Horizons to Sports Medicine
Will Marijuana Stocks Be the Next Meme Stocks & See Exponential Gains?
Buy Rating Initiated on $SNDL with $6 to $8 PT.
CBD legislation in 2021 to overrule FDA
SNDL will be $6 or $8 this year by CWEB
CWEB Analyst’s have initiated a BUY Rating for Sundial Growers Inc. (NASDAQ: SNDL) and potential upside of $6-$8 in 2021
Mentions
Honestly, the NEM put is on Gold could help, then my last $100 I put into a CWEB call (leveraged 2x China) so hoping to recover something but holding the rest until death. I'm ok with this.
[Glass House Brands Announces Hemp Research and Development](https://www.globenewswire.com/news-release/2025/04/09/3058334/0/en/Glass-House-Brands-Announces-Hemp-Research-and-Development-Agreement-with-the-University-of-California-Berkeley.html) >Orrin Devinsky, MD, Glass House’s Medical and Science Advisor to the Board of Directors and a Professor of Neurology, Neuroscience and Psychiatry, who was the lead investigator in the studies on cannabidiol leading to FDA approval Orrin Devinsky is an advisor to Glass House? Idk how I missed this. [Orrin has been all over the place regarding CBD/hemp](https://www.reddit.com/r/weedstocks/comments/1h5ihyn/comment/m071792/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button). He was the lead in developing the CBD medication Epidiolex (Jazz Pharma). Then he joined Tilray in 2017. He's currently with Akita Biosciences with Robert Hanson from Constellation Brands. And he's chief medical advisor of the [CWEB/BAT joint venture](https://defloria.bio/) pursuing FDA approved CBD medication.
Hold, or sell Chinese stocks (VNET, BABA, BIDU, TCEHY)? Anyone invested in CWEB or YINN- China BULL ETFs (2x!) -OR- China Bea ETFs?; \^This is the closest I come to placing options.
There isn't one that covers all 10. But the following cover most of them: Samsung CSI China Dragon ETF Direxion Daily FTSE China Bull 3X Shares ETF (YINN) CWEB KWEB Hang Seng Tech ETF
Is this theoretical or is there an ETF with these bundled already? As far as I am aware, I only know of CWEB and KWEB.
KWEB CWEB BABA 
CWEB going strong today on no news and all other names falling. What an industry
MJBizDaily pumping 2025 stocks with a [guest column by Tiby Erdely](https://mjbizdaily.com/why-2025-could-be-a-banner-year-for-cannabis-investors/). Funny how it doesn't mention hemp whatseover though, because Tiby Erdely is from KEY Investment Partners. KEY employ one of the lobbyists for the US Cannabis Roundtable (**David Culver**) who came from Canopy Growth and prior to that lobbied for big alcohol. KEY also has Canopy's former US THC strategy head on their advisory board. They also have a person focused on cannabis who works at John Boehner's law firm. Most importantly, KEY Investment Partners are early investors in BAT/OGI hemp investment Open Book Extracts. David Culver had two clients when he was lobbying for the US Cannabis Council (now Roundtable). Those were the [US Cannabis Council](https://lda.senate.gov/filings/public/filing/bf89a8d4-bd9f-4c04-b98a-dfa8b0affb03/print/) and [Open Book Extracts](https://lda.senate.gov/filings/public/filing/98fbe479-990f-46d1-8f56-641cac002612/print/). Soon after that, CWEB and Open Book would help form a new advocacy group called ONE Hemp. After that group was formed, Culver stopped lobbying for Open Book and [started lobbying for ONE Hemp](https://lda.senate.gov/filings/public/filing/331bb7d8-8a75-4a71-9379-bc80f84f36b9/print/). Tiby Erdely's KEY Investment Partners [aren't even really invested in publicly traded US Cannabis](https://keyinvestmentpartners.com/portfolio/). So it's odd they are writing articles saying that they are undervalued. Wouldn't it make sense to invest in them before telling others to invest in them?
CWEB talking a bit about their CBD clinical trials through their BAT joint venture. They are using CBD dosages up to 680mg in a dose. We really need to see a safe daily dosage of CBD for general consumers, similar to what the UK has. Then we can actually have a clear separation between low-dose branded CBD wellness products, and high dose medical CBD treatments.
KWEB and CWEB bouncing
Robert Hanson was a President at Constellation Brands, and until earlier this year he was with **Canopy Growth**. Robert Hanson became a board advisor to Akita Biosciences a few months ago. Akita launched in late 2023, and are developing **novel nasal inhalers**. Akita Biosciences's board also has **Orrin Devinsky**, who was recently on a different nasal inhaler company called Receptor Life Sciences. Through at least late 2022 they were trying for FDA approval of [inhaled dry powder CBD](https://www.businesswire.com/news/home/20221101005095/en/Receptor-Life-Sciences-Opens-Second-Investigational-New-Drug-IND-Application-with-FDA-for-RLS103-Inhaled-Dry-Powder-CBD-for-the-Treatment-of-Rapid-Epileptic-Seizure-Termination-REST). Orrin Devinsky was the lead behind the first FDA approved CBD medication Epidiolex Orrin Devinsky was then chosen in 2023 to lead the FDA joint venture between [BAT and Charlotte’s Web.](https://www.prnewswire.com/news-releases/charlottes-web-forms-joint-venture-with-bat-and-ajna-biosciences-to-seek-fda-approval-for-proprietary-full-spectrum-hemp-extract-botanical-drug-301791858.html) Orrin Devinsky and Robert Hanson [connected at Akita](https://www.prnewswire.com/news-releases/former-president-of-constellation-brands-robert-hanson-joins-akita-biosciences-advisory-board-to-boost-profi-nasal-sprays-brand-and-retail-strategy-302227774.html), and the [very next day](https://www.prnewswire.com/news-releases/introducing-wanderous-by-wana-a-new-online-marketplace-for-direct-to-consumer-hemp-derived-thc-and-cbd-products-302228960.html) was the launch of Canopy’s hemp-derived marketplace, with CWEB as an initial partner. 8/22/2024 - Devinsky and Hanson connect 8/23/2024 - CWEB and Canopy partner Orrin Devinsky has also been the chair of the [medical advisory board for Tilray](https://www.businesswire.com/news/home/20170605005403/en/Tilray-Announces-Medical-Advisory-Board) since 2017. Not sure when/if he left them. He originally was working with Tilray during the time period that Tilray was strategizing with John Boehner, who is connected to BAT and Canopy Growth.
Yea mushroom supplements and drinks are increasing in popularity lately. CWEB even randomly started selling mushroom supplements, and they had never branched out from hemp/CBD before.
CWEB hasn't moved much in either direction since the election results. Is this a sign?? Btw I am down nearly 50%, almost all jy canna positions, but haven't had the heart to sell for a loss yet (6 figure + potential divorce-lol!!). Will hold out until DoJ hearing in Dec/Jan and see where this lands. Glta
Matt Gaetz is certainly one of the most cannabis friendly picks we could've hoped for. His former chief of staff is one of Trulieve's lobbyists too. Matt Gaetz did recently come out against the Florida rec amendment, which was odd. And when he sponsored the first medical cannabis legislation in Florida it was for low-THC cannabis and he was working with [hemp company Charlotte's Web](https://www.browardpalmbeach.com/news/bill-to-legalize-charlottes-web-marijuana-filed-by-florida-rep-matt-gaetz-6439343). CWEB is an investment from British American Tobacco. The same person who [lobbies for Trulieve](https://lda.senate.gov/filings/public/filing/2c91f400-2ca7-4755-8745-a83759cf83fb/print/) also [lobbies for BAT](https://lda.senate.gov/filings/public/filing/0c399568-2eaf-44ba-bff6-8d286be736a1/print/) (Reynold's American). BAT/Trulieve's lobbyist was chief of staff to Matt Gaetz, as well as Jeff Miller, the previous Congressman from Gaetz's district. BAT registered with this lobbyist at the beginning of 2017, which is when Matt Gaetz first took federal office. Trulieve would register with them in 2018. BAT employs another lobbyist, who is the Director of Government Affairs at Reynolds American. This lobbyist also previously worked for Jeff Miller, and then was [legislative director and counsel for Matt Gaetz](https://lda.senate.gov/filings/public/filing/dafc789e-f605-4b87-9c74-ba9cd731e4bd/print/).
In general there aren't a ton of public hemp companies, but I consider most LPs to be hemp plays to varying degrees. You have Tilray, Canopy, OGI all actively involved with US hemp right now. Companies like Cronos technically left the US hemp market a while back, but they [continued to lobby for hemp](https://lda.senate.gov/filings/public/filing/263e53bf-9401-4224-b740-2dd6acdcdbba/print/). I think VFF has some very interesting potential given their Texas connections and CBD interests. High Tide has CBD connections. You get the idea. I think federally legal companies will want to only deal with federally legal products. Some other hemp connections besides the main LPs: **Curaleaf** we know is involved with hemp with gummies/beverages, and has been connected to the hemp industry for years **Green Thumb** has relationships with Cann and Lifted Partners for hemp products. They license their Incredibles brand to Lifted. **Glass House Brands** is actively talking about moving into hemp, and this makes a ton of sense for them. They are all set up to start growing hemp in their new greenhouse if they want to. **Flora Growth** is an intriguing mix of CBD/hemp, beverages, and Germany. They are run by the super sketchy Clifford Starke though (involved in the Aphria short report) so beware. Starke also chairs the US Hemp Roundtable, so he's got significant connections. **Jones Soda** is a smaller company, but a direct way to invest in hemp beverages. This is another company associated with sketchy insiders from the Aphria short report though. **Charlotte's Web** is one of the most well known names in CBD, and one of the few pure play hemp companies you can invest in. They have always been adamant about not touching intoxicating products though, so I'm curious if that changes. CWEB is partnered with Tilray, and have the BAT connection with OGI. **InterCure** isn't a US hemp play, but they deal with medical cannabis and CBD in Israel and the EU. They have relationships with OGI/CWEB/Tilray, so lots of hemp connections. Israel will hopefully revise their CBD laws soon as they were supposed to have done a while back (war delayed things), and once that happens I think InterCure's partnership with CWEB should kick in. **Lexaria Biosciences** deals with CBD a bit, and has had a relationship with InterContinental Beverage Capital, who are into hemp beverages. **Perrigo** is a pharma company that took a stake in CBD company Kazmira a few years back. I assume they are still connected. **Jazz Pharma** of course is very involved with CBD via Epidiolex **Better Choice Company** is a pet care company that has tons of cannabis connections going back years, including Bruce Linton, Authentic Brands Group, Arlene Dickinson, Michael Young, etc.. They were doing CBD years ago, and I expect them to get back into it in the near future. Note that pet care is a CBD-only play, as THC is toxic to cats/dogs. **Lifted Partners** is an ultra penny stock, but they are a hemp company associated with Green Thumb. Absolutely zero liquidity. **Akanda Corp** just got an hemp cultivation license a couple months ago in Canada. Not super related to US hemp at the moment, but I just remember that headline. **Maverick Lifestyle** is a pre-IPO hemp company that Bruce Linton is advising. **Synbiotic** in Germany seems to be the most hemp-focused German company, and they are also associated with Bruce Linton. I'm sure there are some other companies I'm forgetting at the moment. There are definitely some other random ones that have died recently. I can think of Hempacco off the top of my head. Then you have the tobacco/alcohol stocks you could invest in if you are looking for a safer, more long term approach to investing in hemp. I personally had a good bit in BAT, though I sold a large amount of it not long ago after they had run up a lot. I will hopefully roll some cannabis gains back into them in the future.
April 2025 40c CWEB. Just happened a month ago. Looks like it's going to be close! I was at 32c and it was at 50! It tanked massively a few days before expiring and that along with crazy high IV allowed me to roll up and out and save my shares which would have been sold at a 20% loss. I made a post about it.
For a day or two I felt I had sold my CWEB too early. Guess what, it is a little below my selling point now. Without new and more forceful stimulus the run of China stock is over. The best scenario is it will range bond. More likely Shanghai Index will retest the 3000.
I will definitely be talking more about this Tilray/CWEB connection, but might not be until later in the week. Have some stuff going on keeping me fairly busy for a bit.
Blackrock has multiple iShares ETFs (FXI, MCHI). You could get a Direxion 3x levered etf (YINN). Kraneshares has KWEB, an ETF of Chinese internet and tech stocks (CWEB for 2x leverage). Invesco offers CQQQ and PGJ. Pick your poison
Maxed out on KWEB, time to go into CWEB with leverage.
Few companies with significant current market share are ones you can invest into. Here's a bit of a list of some beverage connections: Jones Soda - I think this probably the most direct investment in a current cannabis beverages company you can make. They are associated with sketchy cannabis insiders though (SOL Global). Be careful with them. Canopy Growth - Just released beverages through Wana, which is a strong brand. Would assume they will be a part of Constellation Brands distribution network when cannabis beverages are regulated. Tilray - Just announced hemp beverages. Tilray's greatest strength in this market will be their distribution through AB InBev's distribution network when regulations occur. Curaleaf - Recently moved back into hemp beverages. So far I have only heard about direct-to-consumer distribution. They were supposed to announce real distribution/retail partners, but I have not heard this yet. GTI - Have had a partnership with Cann for a while. I personally see their deal with Circle K as a potential strong distibution network for hemp beverages. Flora Growth - Announced a joint venture for cannabis drinks with Althea Group a few months ago. I have not heard anything come of this yet. Althea's subsidiary is the one who manufactures Boston Beer's cannabis beverage in Canada (Teapot). Flora is also associated with sketchy cannabis insiders though. Be very careful with these guys. Lexaria Biosciences - Has made deals to license their DehydraTECH formula to beverage companies, including Intercontinental Beverage Capital (BevNology) as recently as 2022, and Hill Street Beverages years prior to that. Not sure if they have current beverage partners or not though. CWEB/OGI - No current beverages. CWEB supposed to release CBD seltzers in late 2022 though. Was part of the group of companies that had deals with Southern Glazers (CWEB, Tilray, Curaleaf, Canopy). British American Tobacco (OGI/CWEB) is invested in companies that would support hemp beverages though, most notable Open Book Extracts and Trait Biosciences. Cronos Group - No current beverages. Altria has been invested in AB InBev for years though. Cronos is also extremely strongly connected to Gotham Green Partners, and they are the co-investor with British American Tobacco in Trait Biosciences. Flow Beverage Corp - No current cannabis beverages. Have a history of pursuing CBD beverages years ago, and still have some connections to the industry. Tinley - Early company that got into cannabis beverages. They've been pretty quiet for a while, but did just announce a hemp beverage launch at Total Wine the other day. I personally think that basically all the LPs are "hemp" companies to some degree. Imo, companies that will be strongly pursuing federally legal hemp beverages are less likely to be involved with federally illegal recreational cannabis markets.
Why are you selling covered calls? Why you are holding CWEB and YINN? What is your edge? Who told you that selling covered calls is a good idea?
I don't know to calculate the total profit on my options trades for CWEB. I use Etrade and I can't find out how to do it. If I could figure that out, I might feel a whole lot better about this!
hey man, sorry to hear. hopefully your next trade will help you make it all back. imho, not a lot of things if one could do when one sells options on something that ends up going ballistic. don't beat yourself too much. question, you brought down your cost basis from 212 to 46, by wheeling CWEB? ("sold puts on very red days and calls on very green")
Thank you. Your words are very helpful and encouraging. I looked back at my CWEB disaster, and it looks like the entire thing went awry on the initial assignment of 100 shares because after that, I was able to whittle it down and it would have been a win had I not sold these final contracts. Man, I was close. But I should have never spent the time chasing in the first place! I had a hole in my boat and never got it patched, I just kept bailing. Of course, this week the boat made it to the island, and I could have just stepped off but I'm still bailing because I sold covered calls. Okay, that made me laugh.
The merit of a trade shouldn't depend on your previous mistakes. I think you should ask yourself: at what point would you admit that you were wrong on CWEB and let go of that position vs keeping it festering? the next time you trade have a thesis, a plan, and an exit strategy, in case things turn south. If you have those 3 then you only need to start tweaking those until things work out (it might take a long time, but that's another matter). It is a very common mistake to focus on the red on the specific balance and try to remedy that. Don't fall prey to it. If you sell winners and hold on to losers you are watering the weeds and cutting the flowers in the garden. This year I have over 100K of losses in NVDA by selling calls below my basis, it doesn't upset me (I also had it last year https://www.reddit.com/r/thetagang/comments/17lvsp0/defined\_losses\_are\_in\_my\_opinion\_the\_best\_way\_to/) , it's baked into a winning strategy.
I made the mistake of thinking you can make a living selling puts on high IV stocks if you sell them deep enough ITM. Then the Bear market got ahold of me in 2021/2022 and I've just been trying to break even ever since. So, I was selling calls way below my cost basis but above current strike to chip away at my unrealized massive loss on my long position. At one point, I was down 75% on CWEB! I was also selling puts on red days well below current strike for income. Occasionally, I'd take assignment to lower my cost basis. On October 18th my shares will be called away with a 23% loss on my long position. Doesn't feel like a win to me.
Hey, I got paid $80 in CWEB dividends last night! :(
Selling puts are how I got to be a long-term CWEB holder in the first place. And I only sold on very red (>5%) days. Sigh. I guess if I could go back and add up the premium I made selling puts and calls over two years, it might not be so dark. But it sure looks ugly in my portfolio right now as it doesn't show any of that.
At this point, I can go out as far as April, but what strike? My cost basis on CWEB is 45. I could have finally exited this long position with a win if I hadn't sold calls against it.
I don't see how it can hold a 110%+ monthly gain but so far, I've been completely wrong, so... I've got to Oct 18 to come up with a plan. CWEB only has strikes to April so that's not much help.
CWEB is branching out into functional mushroom supplements. They just released three new mushroom gummies.
I sold my CWEB Friday. It was up close to 50% last week. If CWEB is down 10% or more next week I will consider buying it back. The rally is technical. The continuation of upward movement depends on company performance and general economic conditions. I was talking to some veteran stock investors in China. Most of them are looking at the resistance 3090 - 3100 short term. If it breaks the resistance in a convincing manner the market has legs.
Buy CWEB. It has all of those. I’m holding long too! When we start to sink next week. China stocks will rally
Sounds like his comment mostly was addressing THCa as the substitute for rec cannabis, which is what I would expect. I'm very eager to see what happens here. Just the other day CWEB insiders were buying, and they are very connected. And Clifford Starke also just got a bunch of stock granted to him at his company less than a month ago, and he's the chair of the US Hemp Roundtable. Let me know if you see any other comments regarding this. Thanks!
I bought the dip before the last 6 dips and still bag holding like champ  Positions: too many shares of CWEB, fml
Here's the other Form 4 I thought we'd see for CWEB. They bought a lot more this time. [https://archive.fast-edgar.com/20240904/AL24322CZ222Q2Z2222C224P67KGZK229262/](https://archive.fast-edgar.com/20240904/AL24322CZ222Q2Z2222C224P67KGZK229262/)
Looks like a very small [insider buy at CWEB](https://www.sec.gov/Archives/edgar/data/1750155/000175015524000061/xslF345X05/wk-form4_1725383853.xml). Appears to be open market purchases, though it doesn't have the typical note that says so. Less than $2000 total was bought on 8/27 and 8/28. I would guess they bought some more 8/29 or 8/30 and we'll see another Form 4 tomorrow, but that's purely a guess based on how small the amount was on this Form 4.
Right, but that's my point about the distribution aspect of Tilray's beer purchases being critical. As much as they were buying the beer brands, they were buying the distributor relationships and the shelf space at retailers. Those things are incredibly important as a national beverage brand, as opposed to a local or direct-to-consumer brand. The beverage market is extremely competitive, as you say. Take a recent trendy beverage like Celsius. They had been around for a long time, but took off when they started being distributed by Pepsi. Pepsi had a hemp oil Rockstar in early 2022, and one of the prominent investors in Celsius (Kevin Harrington) has promoted many CBD products. I would not be shocked at all to see a Celsius with CBD in the near future. BioSteel is actually a great topic I could talk a while about. They were bought right before the FDA crashed the CBD industry, so they actually never really became a CBD drink. Also Canopy had identified an issue where 2019 emulsion technology was causing CBD to adhere to liners of beverages. Dosages were varying wildly. Essentially there were just lots of issues in late 2019 with beverages, and then the pandemic hit. Canopy never stood a chance, given how much they'd invested in hemp/CBD/beverages. But companies really seemed to have figured it out lately, judging by how hemp beverages are taking off. I don't think Constellation Brands and AB InBev just abandoned the idea of cannabis beverages after 2019. Canopy has just made the move. Right now there is a federally legal THC market that seems to be here to stay, so I think there's lots of opportunity. Also I feel like I have to clarify that I'm not actually a big investor in Tilray, though I have some. I am way bigger into OGI/CWEB for my hemp exposure.
Curaleaf, Canopy, and CWEB were all closely associated with David Culver's lobbying work, and they are all now in their own hemp product marketplaces. Definitely feels like they are confident that the bill Culver was talking about a while back will materialize. Culver was originally with Canopy, and has since joined the investment company behind the BAT/OGI hemp investment Open Book Extracts, called KEY Investment Partners. KEY also has the former head of Canopy's US THC strategy on the team. https://keyinvestmentpartners.com/advisory-board/
I've been digging into patents off and on for a while. There are patents for methods of [converting THC to CBN](https://patents.justia.com/patent/11472786) for [water-soluble formulations](https://patents.justia.com/patent/20220202710) for [hemp plants themselves](https://patents.justia.com/patent/10888059) and all kinds of stuff like that. Canopy Growth and Charlotte's Web seem to have a lot more patents than other hemp/cannabis companies, based on what I've seen so far. I've also learned that [plant variety patents are not as good as utility patents](https://hempindustrydaily.com/are-hemp-plant-breeders-ramping-up-on-utility-patents-to-protect-novel-varieties/), which offer stronger protection but are expensive and time consuming to obtain. *"Some consider utility patents the best option for cannabis breeders because they cover both sexually and asexually propagated new varieties, and because plant breeders can make multiple claims to cover the specific elements of a plant.* *In addition to varieties, utility patents can protect genes, traits, methods and plant parts."* [CWEB got the first hemp strain utility patents in early 2021](https://www.prnewswire.com/news-releases/charlottes-web-secures-us-utility-patents-for-two-new-hemp-varietals-with-superior-cannabinoid-expression-301206788.html). *'Lindorea' and 'Kirsche' are the world's first two allowed U.S. Utility Patents reading on feminized hybrid hemp plants.*
Used this summer draw down to accumulate as much as I could. Going to sit tight and hold into elections. My thesis has not changed, still think schedule 3 is on track and SAFER passes lameduck. Even if we only get schedule 3, it's still a game changer. I'm not a fan of MSOS so created my own canna portfolio. Currently holding these names: TLRY at $4.30 cad TRUL at $9.50 cad VRNO at $5.08 cad ASCEND at $0.88 usd CRESCO at $2.29 cad VEXT at $0.23 cad CWEB at $0.24 cad CBST at $0.45 cad PLNT at $0.56 cad VFF at $1.02 usd I'm here during the good times and the bad. Gut tells me we'll be happy when all is said and done. Good luck everyone!
I have investments in Charlotte's Web, Organigram, and British American Tobacco as my primary hemp related companies. CWEB especially is super risky though, so I don't usually like to advocate for people investing in them. I also think all the other LPs are actually hemp plays to various degrees, with Tilray being the one most openly pursuing hemp. I have some Tilray, but not a ton, as well as various other LP investments. Canopy was the LP most heavily pursuing hemp in 2018-2019, but it's hard to tell what they're doing right now. I really don't trust Curaleaf, but they are also obviously interested in hemp. I think GTI is possibly the more underrated hemp play with the MSOs. Curaleaf is just now getting into hemp beverages, but GTI has been connected to Cann for a long time, and they are already the most popular hemp beverage. I personally assumed the whole GTI / Boston Beer rumor was probably about hemp beverages, as a federally legal product within their specialty is the only thing that made sense for Boston Beer to pursue. I am also watching CBD regulations in Israel, as they are supposed to loosen soon, and I have investments in Israel company InterCure. They have deals with both OGI and CWEB, so there is nice synergy for me there if things work out. Miracle Gro is someone I expect to make some sort of hemp move, but that's just an educated guess and I have a decent size position in Miracle Gro so I'm biased. Other than that there are several penny stocks I follow, but I don't like to mention them much because they aren't good investments and/or have extremely sketchy management. The hemp industry is so crushed that there aren't very many hemp-focused companies that you can even invest in, and most of those are nearly bankrupt.
I am a fan of the Charlotte's Web, Organigram, British American Tobacco group of companies, in terms of relatively safe ways to be exposed to the hemp industry. I think all the LPs are, or will be, hemp plays to some degree. Tilray and OGI are both talking about it. Tilray has their hemp foods and wants to do beverages, while OGI has the CWEB connection via BAT, and OGI invested in Open Book Extracts, who do hemp products. High Tide and VFF both have CBD investments. Cronos and Aurora technically pulled out of the US CBD market a while ago, but Cronos never stopped lobbying for CBD, so I expect them to be back. InterCure in Israel is a favorite of mine as well. Mostly medical cannabis at the moment, but they have a deal with Charlotte's Web to distribute their products once CBD regulations change in Israel. This should have already happened but the war delayed it. Given that InterCure also has a supply deal with OGI, I see this as a partnership that will continue into the future. Could be good entry into the EU as well. Jones Soda and Flora Growth are both into hemp/CBD, but are both connected to very sketchy insiders (SOL Global crew), so there are significant risks in that regard. Lexaria Biosciences is doing research for CBD drugs and they license their CBD tech, so I follow them. Better Choice Company is a pet company that's long been associated with cannabis insiders. I'm watching to see them get back into CBD. Lifted Partners is a hemp products company I've been watching after finding out GTI licenses their brands to them. Flow Beverages is a beverage manufacturer I'm watching to get back into CBD. They have connections to Tilray/OGI/BioSteel, and they were originally going to make Gwynyth Paltrow/HEXO's CBD drink back in 2019. Synbiotic in Germany seems to be the most hemp focused of the German companies. They are also an investment by Bruce Linton, who has been very focused on hemp since leaving Canopy. He had a SPAC that was pursuing industrial hemp products, then he invested in Synbiotic, and earlier this year he joined the advisory board of a hemp cigarette company preparing to IPO. There's a few other random penny stocks. Long story short is that there aren't a lot of non-penny stocks that give you good exposure to the hemp industry, because that industry has been crushed so hard.
I agree. They were involved with the UFC years ago for CBD. https://www.ufc.com/news/aurora-cannabis-and-ufc-join-forces-advance-cbd-research-education-and-product-development?language_content_entity=en I can make a very strong case that the ACB/Coke rumors from 2018/2019 were true. I think I can even make a case that it was going to be ACB and CWEB partnering back then. I think the CBD recovery drink market is going to be huge. Who is someone that is connected to the UFC, CBD drinks, as well as Elon Musk? Joe Rogan. Rogan currently has a CBD drink partnership with the "K*ll Cliff" drinks. Back in 2018 the CEO of Charlotte's Web was Hesaam Moellam, who had come to Charlotte's Web directly from Joe Rogan's supplement company Onnit.
Really appreciate tagging this post, i haven't followed CWEB in some time since I posted this, will add it to the watchlist. Didn't know they signed a deal with Walmart :)
I just bought my CWEB. Now it will move. They signed a deal with WALMART to supply the CBD products soon to hit the shelves> :) Cheers.
A few months ago I placed an order for 1K shares of CWEB. It took 2 days to fill despite the **very** low stock price.
CWEB has good products that seem to be effective.
I've been super interested in Trait for a while. They've had big time advisors since 2019. Before Gotham Green and BAT were investors, they were connected to Aurora/Aphria/Cronos back in 2018/2019. Here's a [comment](https://www.reddit.com/r/weedstocks/comments/1clcrpv/comment/l2tig20/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) I made a while back about Trait Biosciences recent connections to Flow Beverages and BioSteel. Flow Beverages started Cizzle Brands with the Biosteel co-founder. Pete Carr is one of Trait's advisors. He's from Bacardi, and recently got promoted to head their global growth. Tenacious Labs is a company started by a member of the Bacardi family. Tenacious Labs are invested in lots of [CBD companies](https://www.tenacious-labs.com/brands). One of which manufactures [CBD seltzers](https://tenaciouslabsmanufacturing.com/products/cbd-infused-sparkling-beverage). Tenacious Labs recently combined with [Artemis Growth](https://www.tenacious-labs.com/news/artemis-growth-partners-and-tenacious-labs-unite-to-create-europes-largest-cannabis-investment-platform). The founder of Artemis Growth is the same person who is an investor and on the board at Bloomwell Group with **Boris Jordan of Curaleaf**. In 2022 we had Canopy Growth, Charlotte's Web, Tilray, and Curaleaf all partnered for CBD distribution with **Southern Glazers**, which was originally a business combination put together[ by Bacardi](https://www.distillerytrail.com/blog/bacardi-partners-southern-wine-spirits-glazers-form-behemoth-distribution-network/). In 2022 we also had Tilray (Pres of Canada) and CWEB (CEO) with high level executives who had recently worked at Bacardi.
Thanks for sharing, Geo. Let's see if this materializes into something meaningful. Either I am holding CWEB through farm bill amendments that are in the pupeline to be announced by the end of this year/early next year. Glta
I am hoping they announce some kind of beverage play soon. I have been following Flow Beverages for a while, as they have BioSteel, OGI, and HEXO connections, and were doing CBD beverages back in 2019. Flow also has a connection (Ronan Levy) to the water soluble CBD tech company Trait Biosciences, who are funded by BAT and Gotham Green Partners. CWEB claimed they were going to release CBD drinks in late 2022. At the time this was also when Trait was supposed to be releasing their tech. Last news from Trait I heard the release was moved back and supposed to be Q1 2024. I noticed that at the same time CWEB went up like 50% on 500k volume earlier today that almost simultaneously Flow also had a really big jump on much higher volume than is typical for them. Just hypothesizing based on stock movement and connections. Don't invest in penny stocks based on this please. https://www.prnewswire.com/news-releases/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners-and-advances-commercialization-of-unique-water-soluble-cannabinoids-301953852.html "The financing will support Trait's partnerships with contract manufacturers and go-to-market partners, and Trait expects a 1Q 2024 launch of its first-generation water-soluble CBD."
What's going on with CWEB ?¡ I was able to snag 20k at 18 cents. But price action seems very odd.
That old connection is why I'm asking. Lots of people were with Southern Glazers for CBD beverages in 2022, including Tilray, Curaleaf, Canopy, and CWEB. This was the time period that Curaleaf said they ran into supply chain issues with their beverages. I am pretty sure something happened with Southern Glazers. Not sure if it's related to their price-fixing investigation, or maybe they weren't comfortable with hemp THC, but they seem to have gotten out of the CBD beverage market. https://www.just-drinks.com/news/southern-glazers-wine-and-spirits-ends-centrs-cbd-beverage-distribution/ I am guessing this is the supply chain issue Boris was talking about, but that's purely my guess. I focus a lot on how important distribution is for these hemp beverage companies. Tilray talks a ton about their distributors. Part of the highlight of the AB InBev acquisition was about how it gave them access to AB InBevs distribution network.
TLDR: Besides being the largest Israel company, they have solid financials with growth potential domestically and internationally. I think they are a sneaky good EU play. They also fit extremely nicely into my focus on CBD, having CWEB/OGI partnerships and Israel being set to expand CBD. I kept trying to summarize financials briefly, but it's a bit complicated. Their last one was for 2nd half of 2023, right when the war started, and their main facility was in the attack zone. They're entitled by law to get reimbursed for any damages, and they've started receiving that, but a brief summary of recent numbers would be misleading. Best to look at [1st half 2023](https://www.intercure.co/news-releases/news-release-details/intercure-announces-record-revenues-first-half-2023-over-14) for a better sense of how they'll look moving forward. In their more [recent release](https://www.businesswire.com/news/home/20240430357217/en/InterCure-Announces-FY2023-Results-Revenue-of-NIS-356-million-and-Adjusted-EBITDA-of-NIS-61-million) their revenue was heavily impacted by war starting. They were projecting sequential double digit growth in 2024 though, so hopefully back to full strength now. Other general financial stuff: Positive cash from operations recently and positive EBITDA for a long time. Nothing looks crazy with their assets/liabilities to me. Goodwill could be lower. High insider ownership (43% - 8 people). Market cap is still just $150M, which I think is <1x yearly revenue if they're back to normal. When comparing scale of business, consider that Israel is less than half of a Florida in population. InterCure is the largest Israel company. Idk I don't see any major red flags financially (let me know if you do), but it is complicated because of recent events. It's the growth story I'm most interested in, as I think they should "win" the Israel market and they also have strong international ambitions and partners. [Israel just expanded medical cannabis access in April](https://www.nasdaq.com/press-release/imc-applauds-the-april-1st-implementation-of-the-new-israeli-cannabis-regulation). Combine that with the [sharp rise in cannabis prescriptions already reported in November](https://www.marijuanamoment.net/medical-marijuana-prescriptions-rise-sharply-in-israel-amid-war-with-hamas-government-says-as-patients-seek-relief-from-ptsd-and-pain/), and I can see some solid growth quarters coming. InterCure has been acquiring their [own cannabis pharmacies too](https://www.intercure.co/news-releases/news-release-details/intercure-signs-definitive-agreement-acquire-leon-cannabis). InterCure's international partnerships are very interesting: Organigram / Charlotte's Web / Tilray / Cookies / TYSON 2.0 / Binkse (among others) InterCure should be expanding into Germany soon. They are partnered with Cookies for retail stores in Austria and the UK. They are the exclusive partner for TYSON in Germany/UK/Israel/Australia. As a big Organigram and Charlotte's Web guy, I am also closely watching the expansion of CBD in Israel. A couple years ago they said they were finally [removing CBD from the dangerous drug ordinance](https://hemptoday.net/israel-moves-to-normalize-cbd-2-year-path-to-market-expected/). This would greatly expand the CBD market in Israel, which is more restricted than you would think given their long history with cannabis. Removal from the DDO would finally allow CBD sold over the counter and in cosmetic and food products. It's already supposed to have happened in February 2024. In InterCure's financials they say: *"In August 2023, the IMCA published......the report refers to the current regulatory status of CBD,* ***providing timelines for the removal of CBD from the DDO in February 2024****.* ***However, this has yet to have occurred****."* InterCure's agreement with Charlotte's Web doesn't actually kick in until CBD is removed from the DDO. InterCure already has a partnership established to distribute CWEB products via Altman Health: *"In March 2022, we announced a strategic partnership with Altman Health.....1,700 points of sale, including all major pharmacies.....Intercure and Altman Health plan to register, market and distribute Charlotte’s Web branded products in Israel.....marks a significant milestone for the company’s CBD expansion strategy, the joint venture has not been established yet due to current CBD regulations in Israel. CBD is still classified as a controlled substance in Israel and meaningful operations are not allowed until it is delisted."*
Reposting from the daily because it's more relevant here: Was just reading OGI's earning's call. A few things just regarding strategy to note. **They talk multiple times about the hemp-derived beverage and edible space. When talking about Open Book Extracts:** *"Through this investment, Organigram stands to gain invaluable insights into the U.S. landscape by leveraging OBX's extensive experience with key players in the U.S. cannabis market."* * OBX has lots of Acreage/Canopy connections *"Moving forward, we expect to collaborate with OBX on product launches in the U.S., capitalizing on the explosive growth of the hemp-derived THC market for edibles and beverages."* **They also talk about the new nano-emulsion technology they are working on:** *"You've heard me speak about the nano-emulsion technology that is being worked on....the patent-pending nano-emulsion technology aims to unlock...."* *"The nano-emulsion production equipment was recently transported to Organigram's Winnipeg facility in April, and the company is preparing to scale up production and sales for these gummies in the fall."* * I think this is the CBD tech I've talked a lot about recently, being launched by [Trait Biosciences](https://traitbio.com/distilled/). They are another of BAT's investments, like Open Book Extracts. * OGI has a 50% market share of CBD gummies, so this makes sense **Later on in questions, more hemp-derived and emulsion discussion:** “….we're very excited about the hemp-derived THC market for ingestibles, for both beverages and for edibles.” “What excites us about this is the direct-to-consumer opportunities that you could move products across state lines.” “We see the opportunity of using the nano-emulsion technology that we're developing in some of the products that we take to the market in the U.S. at some point in the future.” **Regarding distribution in the US:** “So nothing in the short-term in terms of using the BAT distribution network, we'd be looking at how OBX is getting products out. We'd be looking at other partners that we could leverage.” * I feel like OGI might partner with Tilray for distribution. They have multiple strong connections including Beena/Irwin and Tilray/CWEB deal. * Tilray has also talked recently about the potential of the hemp-derived market * I had a theory that everybody was going to [use Southern Glazer's](https://www.reddit.com/r/weedstocks/comments/1cnqzkm/comment/l3dbze3/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) for distribution in late 2022, but I think Southern Glazer's had some issues. Canopy was also signed with Southern Glazers early on. * One of the top things Tilray highlighted with their AB InBev purchase was [access to their distribution channel](https://tilray.gcs-web.com/news-releases/news-release-details/tilray-brands-announces-agreement-acquire-eight-beer-beverage).
Was just reading OGI's earning's call. A few things just regarding strategy to note. **They talk multiple times about the hemp-derived beverage and edible space. When talking about Open Book Extracts:** *"Through this investment, Organigram stands to gain invaluable insights into the U.S. landscape by leveraging OBX's extensive experience with key players in the U.S. cannabis market."* * OBX has lots of Acreage/Canopy connections *"Moving forward, we expect to collaborate with OBX on product launches in the U.S., capitalizing on the explosive growth of the hemp-derived THC market for edibles and beverages."* **They also talk about the new nano-emulsion technology they are working on:** *"You've heard me speak about the nano-emulsion technology that is being worked on....the patent-pending nano-emulsion technology aims to unlock...."* *"The nano-emulsion production equipment was recently transported to Organigram's Winnipeg facility in April, and the company is preparing to scale up production and sales for these gummies in the fall."* * I think this is the CBD tech I've talked a lot about recently, being launched by [Trait Biosciences](https://traitbio.com/distilled/). They are another of BAT's investments, like Open Book Extracts. * OGI has a 50% market share of CBD gummies, so this makes sense **Later on in questions, more hemp-derived and emulsion discussion:** “….we're very excited about the hemp-derived THC market for ingestibles, for both beverages and for edibles.” “What excites us about this is the direct-to-consumer opportunities that you could move products across state lines.” “We see the opportunity of using the nano-emulsion technology that we're developing in some of the products that we take to the market in the U.S. at some point in the future.” **Regarding distribution in the US:** “So nothing in the short-term in terms of using the BAT distribution network, we'd be looking at how OBX is getting products out. We'd be looking at other partners that we could leverage.” * I feel like OGI might partner with Tilray for distribution. They have multiple strong connections including Beena/Irwin and Tilray/CWEB deal. * Tilray has also talked recently about the potential of the hemp-derived market * I had a theory that everybody was going to [use Southern Glazer's](https://www.reddit.com/r/weedstocks/comments/1cnqzkm/comment/l3dbze3/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) for distribution in late 2022, but I think Southern Glazer's had some issues. Canopy was also signed with Southern Glazers early on. * One of the top things Tilray highlighted with their AB InBev purchase was [access to their distribution channel](https://tilray.gcs-web.com/news-releases/news-release-details/tilray-brands-announces-agreement-acquire-eight-beer-beverage).
Yes the point that all cannabis is mostly THCa is one of the primary things I'm trying to explain to people. However most batches you get from MSOs are higher than 0.3%. Some are not. It's hard to consistently produce that. Just like hemp, if they test hot that crop would be a total loss and all get burned. I'm concerned that the seeds for strains that are legitimately stable, and able to consistently produce federally legal products, are currently being developed by big ag and big tobacco, etc.. BAT via OGI just invested in Phylos recently, and BAT is probably the largest company openly focused on hemp and CBD. CWEB (part of the BAT/OGI network) was the first to patent a hemp strain in 2019 with <0.3% THC. https://www.cannabisbusinesstimes.com/news/stanley-brothers-charlottes-web-cbd-hemp-plant-variety-patent/ "In 2014, one year after the debut of Weed, the Stanley brothers committed to keeping Charlotte’s Web beneath the 0.3-percent THC threshold—effectively developing it into a hemp cultivar." "In the public documents, Stanley described a plant type capable of producing 6.24-percent CBD content and 0.27-percent THC content." "And as we’re seeing with the 2019 harvest season, “hot” crops are a major problem in the industry. Crops that test above that 0.3-percent THC limit must be destroyed, according to most state statutes, and so one of the important educational trends in the business right now is to identify reliable hemp varieties that won’t leap past that threshold when it comes time to test and cut the crop. As the industry matures over these next few years, it may come to pass that clone stock becomes a more vital part of a grower’s arsenal"
CGC most likely to go bankrupt before CWEB does 😅
People might've forgotten, but BAT/CWEB have already started going down the botanical drug development pathway for a new CBD drug. https://in.investing.com/news/charlottes-web-enters-jv-with-bats-and-ajna-to-pursue-fdaapproval-for-a-novel-botanical-drug-to-target-a-neurological-condition-432SI-3589442
CWEB has a few directors not standing for re-election. They are proposing 2 replacements right now. One is Jared Stanley (one of the founders). The other is Maureen Usifer who is a chair of the audit committee at BlackRock TCP Capital Corp, along with multiple other BlackRock connections. [archive.fast-edgar.com/20240429/AOZZV22CZ22BU9Z2222P2ZZZDVTUZZXS4C62/](https://archive.fast-edgar.com/20240429/AOZZV22CZ22BU9Z2222P2ZZZDVTUZZXS4C62/) Usifer also spent 4 years at Seventh Generation recently. This is the same Unilever company that directly connected to one of the last people they added to their board (Angela McElwee). CWEB also recently added former Ben & Jerry's CEO Matthew McCarthy, with B&J being another Unilever company. In terms of CWEB/Unilever connections, I think it's also worth noting that during the initial CBD hype phase in 2018 CWEB's CEO (Hess Moallem) had come directly from Onnit, which was a supplement brand that would be bought by Unilever a couple years later.
Looks like the only good thing I did recently was sell trulieve , CBST, and CWEB at recents highs. Def looking to reload. Could be a long summer tho :/ Anne are you ok? Cause our stocks arent
OGI just invested in a hemp extract company. Obviously they already have the CWEB connection too. https://www.businesswire.com/news/home/20240326681362/en/Organigram-Invests-in-U.S.-Based-Open-Book-Extracts-Representing-Inaugural-Jupiter-Investment Tilray has talked about CBD and Delta 9 recently, saying they will have to be into it. Both CBD and D9 beverages make perfect sense given their legality, and ability to be sold nationwide. Jones Soda recently partnered with Tilray and just released Delta 9 beverages. Cann is the most popular cannabis beverage. It is hemp derived, and has long been associated with MedMen/HEXO. Snoop just released a Delta 9 beverage (Do It Fluid). ACB and CRON have shared minor cannabinoid biosynthesis IP together recently. Part of the final order on CBD, etc will be categorizing synthetically produced CBD the same as natural, as long as it's <0.1% THC. https://www.prnewswire.com/news-releases/aurora-and-22nd-century-group-license-foundational-biosynthesis-ip-to-cronos-group-301444681.html Might explain why both ACB and CRON both pulled out of their hemp derived CBD companies right after last year's DEA supply chain conference. This would also explain why CRON still lobbies mostly just for CBD in the US. https://lda.senate.gov/filings/public/filing/263e53bf-9401-4224-b740-2dd6acdcdbba/print/ You also have BAT and CRON (Btomorrow Ventures and Gotham Green) teaming up to fund Trait Biosciences. Trait has been working on water soluble cannabinoid tech since 2017. BAT and Gotham closed on financing for them in late 2023. They claimed they were ready to launch their product finally in the first quarter of 2024. This coincides perfectly with the expected final order on the 2018 Farm Bill that is currently supposed to be finished sometime in April (4/00/24). https://www.prnewswire.com/news-releases/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners-and-advances-commercialization-of-unique-water-soluble-cannabinoids-301953852.html
Every time I put a bid in for CWEB, as soon as I refresh the page there is a bid 0.0001 above mine. I just kept increasing my bid in increments of 0.0004 or so, and saw the same 0.0001 thing happen instantly every time from 0.2034 to 0.2068.
55k commons HITI, 150k commons CBST, 110k CWEB, 8k GTII are my core positions. Glta
CWEB held out and weathered that last hour drop pretty well.
how can you possibly be in green with CWEB
HITI, CBST, CWEB, and GTII are my long plays, accounting for 90% of my portfolio at the moment. All in green, some more than the others!! Also, have some spare powder to make some quick trades for the beer money. Cheers to the fellow believers of the good old Weed Gods!! Glta
Could maybe be an option, though I personally think it makes more sense to target other beaten down CBD companies to roll up together with CWEB later. Or even a company somewhere in the rest of the hemp supply chain (food, fiber, fuel).
I think it makes more sense to buy some other CBD companies and roll them up into CWEB later. There are probably some incredibly cheap CBD companies out there, because most have not had BAT's financial backing to survive like CWEB has had. If we see Delta 8 get banned there are instantly going to be lots of companies throwing in the towel, because they were only viable as long as they could convert CBD isolate to Delta 8 to sell at a higher price.
How much would CWEB cost? BAT and OGI have apparently been eyeing CWEB for some time. That could be part of raising USD capital. Or raising USD capital could be easier with the large BAT pressence vs raising 30Million + in Canada right now.
The implementation of the Farm Bill could be when they are finally going to ban Delta 8? I have theorized it would make sense to do this at the same time as Schedule 3. They are having the 2024 DEA Supply Chain conference at the end of April. At the previous one they said they were still working on finalizing the Farm Bill related rule (see page 27). [https://www.deadiversion.usdoj.gov/mtgs/supply\_chain/conf\_2023/Boos.pdf](https://www.deadiversion.usdoj.gov/mtgs/supply_chain/conf_2023/Boos.pdf) This powerpoint talks a lot about how synthetic cannabinoids are schedule 1, except they were going to exempt synthetic CBD. If you look at page 22 you see 6 synthetic cannabinoids that got moved to schedule 1 recently. The reporting from this conference even said that new rules were coming for synthetic CBD and Delta 8. [https://www.marijuanamoment.net/dea-official-says-new-rules-are-coming-for-synthetic-cannabinoids-including-cbd-and-delta-8-thc/](https://www.marijuanamoment.net/dea-official-says-new-rules-are-coming-for-synthetic-cannabinoids-including-cbd-and-delta-8-thc/) Now I mentioned a long time ago how I thought that CWEB, OGI, and BAT had figured out their next moves at the 2023 DEA Supply Chain conference. This is when I believe they knew a Delta 8 ban was coming up. [https://www.reddit.com/r/weedstocks/comments/13nz8b5/why\_i\_believe\_charlottes\_web\_cbd\_is\_about\_to\_be/](https://www.reddit.com/r/weedstocks/comments/13nz8b5/why_i_believe_charlottes_web_cbd_is_about_to_be/) Note my timeline in that link starting on 5/3/2023, where CWEB/OGI each make SEC filings, including a confidential treatment order from OGI related to their first BAT investment. Well OGI filed another granting of a confidential treatment order on 3/1/2024 in relation to their BAT investment pool Jupiter. [https://www.sec.gov/Archives/edgar/data/1620737/999999999724000518/filename1.pdf](https://www.sec.gov/Archives/edgar/data/1620737/999999999724000518/filename1.pdf) Early in 2023, Beena Goldenberg of OGI was on a podcast talking about using CBD as a US entry. She mentions how they need the delta 8 stuff cleared up first. They closed on the Jupiter money months ago and have just been sitting on it. [https://seekingalpha.com/article/4580572-organigram-ceo-beena-goldenberg-expanding-beyond-canada-transcript](https://seekingalpha.com/article/4580572-organigram-ceo-beena-goldenberg-expanding-beyond-canada-transcript) OGI's Jupiter made its first investment today, in Open Book Extracts, a leader in hemp-derived extracts and products. Open Book is a BAT investment who they have used to lobby for CBD regulations. Right after CWEB joined the One Hemp alliance, Open Book Extracts terminated with their lobbyist and the One Hemp Alliance picked up lobbying with them. Note that the lobbyist they use only has one other client, which is the US Cannabis Council. [https://www.businesswire.com/news/home/20240326681362/en/Organigram-Invests-in-U.S.-Based-Open-Book-Extracts-Representing-Inaugural-Jupiter-Investment](https://www.businesswire.com/news/home/20240326681362/en/Organigram-Invests-in-U.S.-Based-Open-Book-Extracts-Representing-Inaugural-Jupiter-Investment) [https://lda.senate.gov/filings/public/filing/1337b8e0-4ccc-4b22-b5ee-c6bd74f6ad4b/print/](https://lda.senate.gov/filings/public/filing/1337b8e0-4ccc-4b22-b5ee-c6bd74f6ad4b/print/) [https://lda.senate.gov/filings/public/filing/331bb7d8-8a75-4a71-9379-bc80f84f36b9/print/](https://lda.senate.gov/filings/public/filing/331bb7d8-8a75-4a71-9379-bc80f84f36b9/print/)
OGI invests in Open Book Extracts for their first Jupiter investment. I've talked about these guys a lot. They're one of BAT's other investments, and they were lobbying for CBD using the same lobbyist as the US Cannabis Council. They stopped lobbying once CWEB joined the One Hemp alliance and started lobbying through that. https://www.businesswire.com/news/home/20240326681362/en/Organigram-Invests-in-U.S.-Based-Open-Book-Extracts-Representing-Inaugural-Jupiter-Investment https://lda.senate.gov/filings/public/filing/1337b8e0-4ccc-4b22-b5ee-c6bd74f6ad4b/print/
CWEB financials are out. Nothing crazy. I like the low cash burn this quarter, as that was my biggest worry. [https://www.prnewswire.com/news-releases/charlottes-web-reports-2023-fourth-quarter-and-year-end-financial-results-302095600.html](https://www.prnewswire.com/news-releases/charlottes-web-reports-2023-fourth-quarter-and-year-end-financial-results-302095600.html)
This explains (to some extent) the price action in CWEB today.
The day it rises to extremes will be the day I watch in envy because Im blocked from investing at the moment (european). Nonetheless, CWEB deserves it.
Agree on CWEB, and CBST will most likely run back to HHS highs whenever S3 announcements come through.
CWEB is finally showing some signs of life. Cheers to folks who bought this in 18-20 cent range the last couple of months.
CWEB is expanding more into minor cannabinoids, as opposed to just CBD. Launched a CBN sleep product today. https://www.prnewswire.com/news-releases/charlottes-web-launches-stay-asleep-cbn-gummies-302092445.html
Tin-foil hat theory - was this the cause for an abrupt price action in CWEB yesterday??
Yay CWEB with a big candle in the correct direction for a change
Yea could be. I was watching THCX dump shares there for a bit but they look like they are 100% cash as of yesterday. I also added a bunch after that one big red candle today. I just think it's funny that BAT has already invested like 3x CWEB's current market cap into the company since November 2022 (including the $10M they put up for the joint venture).
They are currently offering me 23% to borrow my CWEB shares to short
CWEB is getting some real ass whipping by the bears lately. It's funny how uni directional it's been since the drop from HHS announcement.
Nothing really CWEB specific, since this post is more about Altria/Cronos and CWEB is with BAT. However, I have mentioned a few times lately that BAT and Gotham Green (Cronos) have been investing together for a few years in a water-soluble CBD tech company called Trait Biosciences. They just closed a funding round in late 2023 where they said they were planning to finally launch their CBD product in 2024Q1. So I think that's something worth keeping an eye on. [https://traitbio.com/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners/](https://traitbio.com/trait-biosciences-closes-on-financing-led-by-bats-btomorrow-ventures-and-gotham-green-partners/) While Cronos claims to have pulled back from the CBD market in the US, their lobbying disclosures indicate that's still their focus. At least in terms of near-term legislative priorities. [https://lda.senate.gov/filings/public/filing/29a627ab-529d-4882-b0d5-e6e937bacb7d/print/](https://lda.senate.gov/filings/public/filing/29a627ab-529d-4882-b0d5-e6e937bacb7d/print/)
u/geologic23 connected dots with CWEB here?
So they have like 2mn more to go..huh! Btw they were able to liquidate their top holding (NOVC) of over 1.5m commons is just one day without affecting the sp one bit. Looks like CWEB isn't that lucky, after all.
THCX liquidated more shares today, sold 340 182 shares of $CWEB $CWBHF
You're welcome. Hopefully we'll see a CWEB rebound soon.
How many CWEB shares does the ETF hold?
Does anyone have insights into this CWEB /CWBHF crash?
I got in a little early with my CWEB position. It's still not bad, but being down 15% pains a bit as I could have picked up another 20k commons with the money. Conscious it'll likely even out in the long run! Glta
Everytime I add some CWEB/CWBHF, it continues to drop
CWEB appoints former Ben & Jerry's CEO to their board. Reminder that Ben & Jerry's are owned by major British CPG company Unilever, and B&J have been talking about CBD ice cream for a while. [https://www.prnewswire.com/news-releases/charlottes-web-holdings-inc-announces-appointment-of-former-ben--jerrys-ceo-matthew-e-mccarthy-to-its-board-of-directors-302055833.html](https://www.prnewswire.com/news-releases/charlottes-web-holdings-inc-announces-appointment-of-former-ben--jerrys-ceo-matthew-e-mccarthy-to-its-board-of-directors-302055833.html) [https://www.benjerry.com/whats-new/2019/05/cbd-statement](https://www.benjerry.com/whats-new/2019/05/cbd-statement)